Van Eck Associates Corp Neogenomics Inc Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 1,360 shares of NEO stock, worth $12,947. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,360
Previous 1,724
21.11%
Holding current value
$12,947
Previous $23,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$187 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$136 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$62.1 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$58.7 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$58.6 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.2B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...